Shenzhen Weiguang Biological Products Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 616.76 million compared to CNY 607.66 million a year ago. Revenue was CNY 616.76 million compared to CNY 607.66 million a year ago. Net income was CNY 137.67 million compared to CNY 120.97 million a year ago. Basic earnings per share from continuing operations was CNY 0.607 compared to CNY 0.5306 a year ago. Diluted earnings per share from continuing operations was CNY 0.607 compared to CNY 0.5306 a year ago.